Clinical Trials Directory

Trials / Unknown

UnknownNCT02311803

Preservation Versus Excision of Denonvilliers Fascia in L-PANP Surgery

Preservation Versus Excision of Denonvilliers Fascia in Laparoscopic Pelvic Autonomic Nerve Preserving Surgery for Male Mid-low Rectal Cancer Patients: a Randomized Controlled Clinical Trial

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
172 (estimated)
Sponsor
Third Affiliated Hospital, Sun Yat-Sen University · Academic / Other
Sex
Male
Age
20 Years – 60 Years
Healthy volunteers
Not accepted

Summary

TME (Total mesorectum excision) is the golden standard of radical resection for mid-low rectal cancer. However, the damage of pelvic autonomic nerve following with TME principle will lead to high incidence of urinary and sexual function disorder. PANP (pelvic autonomic nerve preservation) surgery played a role in decreasing incidence of urinary and sexual function disorder. However, 32%-44% patients still suffered from urinary and sexual function disorder when underwent open (O-PANP-TME) or laparoscopic PANP TME surgery (L-PANP-TME). In the early stage of work, the investigators performed preservation of Denovilliers' fascia in L-PANP-TME to discuss the protection of urinary and sexual function of male mid-low rectal cancer patients. The results showed that preservation of Denovilliers' fascia in L-PANP-TME significantly decreased incidence of urinary and sexual function disorder. In order to further confirm the early work, the investigators design a randomized controlled clinical trial to compare differences in urinary and sexual function protection and long-term outcomes between preservation and excision of Denovilliers' fascia in L-PANP-TME.

Conditions

Interventions

TypeNameDescription
PROCEDUREPreservation of Denonvilliers FasciaIn this group, patients accepte L-PANP surgery without excision of Denonvilliers Fascia
PROCEDUREExcision of Denonvilliers FasciaIn this group, patients accepte L-PANP surgery with excision of Denonvilliers Fascia

Timeline

Start date
2015-02-01
Primary completion
2019-12-01
Completion
2020-04-01
First posted
2014-12-08
Last updated
2019-01-29

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT02311803. Inclusion in this directory is not an endorsement.